Fig. 1

Kaplan–Meier product-limit survival estimates of time to HIV seroconversion by number of females in one’s injection network, including index. HIV, human immunodeficiency virus
Kaplan–Meier product-limit survival estimates of time to HIV seroconversion by number of females in one’s injection network, including index. HIV, human immunodeficiency virus